Research Aurinia settles with Teva, helping stave off potential Lupkynis generic until late 2036By Healthcare Propulsion StaffAugust 20, 20260 Aurinia Pharmaceuticals has struck a patent infringement settlement with Teva Pharmaceuticals, which should help stave off Teva’s proposed generic to…
Research Teva scores rare partial win in CMS price negotiation appealBy Healthcare Propulsion StaffAugust 19, 20260 In their attempts to challenge the Medicare drug price negotiation program, introduced by former President Joe Biden under the Inflation…
